KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Return on Equity (2016 - 2025)

Charles River Laboratories International has reported Return on Equity over the past 16 years, most recently at 0.04% for Q4 2025.

  • Quarterly results put Return on Equity at 0.04% for Q4 2025, down 5.0% from a year ago — trailing twelve months through Dec 2025 was 0.04% (down 5.0% YoY), and the annual figure for FY2025 was 0.04%, down 5.0%.
  • Return on Equity for Q4 2025 was 0.04% at Charles River Laboratories International, down from 0.02% in the prior quarter.
  • Over the last five years, Return on Equity for CRL hit a ceiling of 0.18% in Q2 2021 and a floor of 0.04% in Q4 2025.
  • Median Return on Equity over the past 5 years was 0.15% (2023), compared with a mean of 0.11%.
  • Biggest five-year swings in Return on Equity: increased 14bps in 2021 and later dropped -14bps in 2025.
  • Charles River Laboratories International's Return on Equity stood at 0.16% in 2021, then grew by 9bps to 0.18% in 2022, then fell by -21bps to 0.14% in 2023, then tumbled by -95bps to 0.01% in 2024, then tumbled by -720bps to 0.04% in 2025.
  • The last three reported values for Return on Equity were 0.04% (Q4 2025), 0.02% (Q3 2025), and 0.02% (Q2 2025) per Business Quant data.